CLHIA Member Centre

Login | Register

Comments on Health Canada’s consultation on the proposed amendments to the Patented Medicines regulations


Release Date: 02/13/2018
Staff Reference: Karen Voin

February 13, 2018

Ms. Karen Reynolds
Executive Director
Office of Pharmaceuticals Management Strategies
Strategic Policy Branch
Brooke Claxton Building, 10th Floor
70 Colombine Driveway, Tunney’s Pasture
Ottawa, ON
K1A 0K9


RE: Canada Gazette, Part 1 published December 2, 2017 Health Canada’s consultation on proposed amendments to the Patented Medicines Regulations

The Canadian Life and Health Insurance Association Inc. (CLHIA) appreciates the opportunity to provide further comments on Health Canada’s consultation on the proposed amendments to the Patented Medicines regulations. The CLHIA supports Health Canada’s leadership in reviewing and recommending changes to the Patented Medicines Regulations to assist in reducing the high cost of prescription drugs in Canada while also continuing to incent innovation to ensure that Canadians have access to affordable and necessary medications...